Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

"Role of the adipocyte hormone leptin in cardiovascular diseases - a study from Chennai based Population".

Nalini D, Karthick R, Shirin V, Manohar G, Malathi R.

Thromb J. 2015 Mar 4;13:12. doi: 10.1186/s12959-015-0042-4. eCollection 2015.

PMID:
25762868
Free PMC Article
2.

In-hospital daily insulin dose predicts long-term adverse outcome in patients with diabetes with ST-elevation myocardial infarction treated with successful primary percutaneous angioplasty.

Jeżewski T, Peruga JZ, Kasprzak JD, Bendinger T, Plewka M, Drożdż J, Drzewoski J, Krzeminska-Pakula M.

Arch Med Sci. 2014 Oct 27;10(5):913-9. doi: 10.5114/aoms.2014.46211. Epub 2014 Oct 23.

3.

Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum.

António N, Fernandes R, Soares A, Soares F, Lopes A, Carvalheiro T, Paiva A, Pêgo GM, Providência LA, Gonçalves L, Ribeiro CF.

Cardiovasc Diabetol. 2014 Jun 16;13:101. doi: 10.1186/1475-2840-13-101.

4.

Metabolic consequences of Helicobacter pylori infection and eradication.

Buzás GM.

World J Gastroenterol. 2014 May 14;20(18):5226-34. doi: 10.3748/wjg.v20.i18.5226. Review.

5.

Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era.

Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ.

World J Cardiol. 2014 Mar 26;6(3):100-6. doi: 10.4330/wjc.v6.i3.100. Review.

6.

Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance.

Gruzdeva O, Uchasova E, Belik E, Dyleva Y, Shurygina E, Barbarash O.

BMC Cardiovasc Disord. 2014 Jan 16;14:7. doi: 10.1186/1471-2261-14-7.

7.

A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse.

Marchetti C, Chojnacki J, Toldo S, Mezzaroma E, Tranchida N, Rose SW, Federici M, Van Tassell BW, Zhang S, Abbate A.

J Cardiovasc Pharmacol. 2014 Apr;63(4):316-22. doi: 10.1097/FJC.0000000000000053.

8.

Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study.

Strand E, Pedersen ER, Svingen GF, Schartum-Hansen H, Rebnord EW, Bjørndal B, Seifert R, Bohov P, Meyer K, Hiltunen JK, Nordrehaug JE, Nilsen DW, Berge RK, Nygård O.

BMC Med. 2013 Oct 8;11:216. doi: 10.1186/1741-7015-11-216.

9.

Hypoglycemia: The neglected complication.

Kalra S, Mukherjee JJ, Venkataraman S, Bantwal G, Shaikh S, Saboo B, Das AK, Ramachandran A.

Indian J Endocrinol Metab. 2013 Sep;17(5):819-34. doi: 10.4103/2230-8210.117219. Review.

10.

Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the β cell.

Kuliawat R, Klein L, Gong Z, Nicoletta-Gentile M, Nemkal A, Cui L, Bastie C, Su K, Huffman D, Surana M, Barzilai N, Fleischer N, Muzumdar R.

FASEB J. 2013 Dec;27(12):4890-8. doi: 10.1096/fj.13-231092. Epub 2013 Aug 30.

11.

Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction.

Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Shurygina E, Barbarash O.

Diabetes Metab Syndr Obes. 2013 Aug 13;6:293-301. doi: 10.2147/DMSO.S46627. eCollection 2013.

12.

Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction.

Karrowni W, Li Y, Jones PG, Cresci S, Abdallah MS, Lanfear DE, Maddox TM, McGuire DK, Spertus JA, Horwitz PA.

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2245-51. doi: 10.1161/ATVBAHA.113.301585. Epub 2013 Jul 18.

13.

Decreased long-chain fatty acid oxidation impairs postischemic recovery of the insulin-resistant rat heart.

Harmancey R, Vasquez HG, Guthrie PH, Taegtmeyer H.

FASEB J. 2013 Oct;27(10):3966-78. doi: 10.1096/fj.13-234914. Epub 2013 Jun 27.

14.

The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) -- a prospective population-based study.

Tillin T, Hughes AD, Mayet J, Whincup P, Sattar N, Forouhi NG, McKeigue PM, Chaturvedi N.

J Am Coll Cardiol. 2013 Apr 30;61(17):1777-86. doi: 10.1016/j.jacc.2012.12.046. Epub 2013 Feb 28.

15.

Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease.

Hall GC, McMahon AD, Carroll D, Home PD.

PLoS One. 2012;7(11):e49908. doi: 10.1371/journal.pone.0049908. Epub 2012 Nov 14.

16.

Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study.

Engbersen R, Riksen NP, Mol MJ, Bravenboer B, Boerman OC, Meijer P, Oyen WJ, Tack C, Rongen GA, Smits P.

Cardiovasc Diabetol. 2012 Oct 10;11:124. doi: 10.1186/1475-2840-11-124.

17.

Oxidative stress and myocardial injury in the diabetic heart.

Ansley DM, Wang B.

J Pathol. 2013 Jan;229(2):232-41. doi: 10.1002/path.4113. Review.

18.

Discontinuation of antihyperglycemic therapy after acute myocardial infarction: medical necessity or medical error?

Lovig KO, Horwitz L, Lipska K, Kosiborod M, Krumholz HM, Inzucchi SE.

Jt Comm J Qual Patient Saf. 2012 Sep;38(9):403-7.

19.

Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics.

Chakrabarti AK, Singh P, Gopalakrishnan L, Kumar V, Elizabeth Doherty M, Abueg C, Wang W, Gibson CM.

Cardiol Res Pract. 2012;2012:704314. doi: 10.1155/2012/704314. Epub 2012 Jul 9.

20.

How to best manage glycemia and non-glycemia during the time of acute myocardial infarction.

Hirsch IB, O'Brien KD.

Diabetes Technol Ther. 2012 Jun;14 Suppl 1:S22-32. doi: 10.1089/dia.2012.0095. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk